81 related articles for article (PubMed ID: 10348542)
1. A comparison of arterial versus venous-activated clotting time in patients with congenital heart disease undergoing cardiac catheterization.
Zeevi B; Bar-Mor G; Livne M; Berant M
Catheter Cardiovasc Interv; 1999 Feb; 46(2):194-6. PubMed ID: 10348542
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous transluminal coronary angioplasty: comparison of arterial vs. venous activated clotting time.
Pesola GR; Johnson A; Pesola DA
Cathet Cardiovasc Diagn; 1996 Feb; 37(2):140-4. PubMed ID: 8808068
[TBL] [Abstract][Full Text] [Related]
3. A comparison between arterial- and venous-sampled activated clotting time measurements.
Zisman E; Rozenberg B; Katz Y; Ziser A
Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
[TBL] [Abstract][Full Text] [Related]
4. Rational approach to use of heparin during cardiac catheterization in children.
Grady RM; Eisenberg PR; Bridges ND
J Am Coll Cardiol; 1995 Mar; 25(3):725-9. PubMed ID: 7860920
[TBL] [Abstract][Full Text] [Related]
5. [The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory].
Dellavalle A; Steffenino G; Ribichini F; Russo P; Conte L; Conte E; Uslenghi E
G Ital Cardiol; 1995 Apr; 25(4):445-51. PubMed ID: 7642051
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility and variability of activated clotting time measurements in the cardiac catheterization laboratory.
Doherty TM; Shavelle RM; French WJ
Catheter Cardiovasc Interv; 2005 Jul; 65(3):330-7. PubMed ID: 15864806
[TBL] [Abstract][Full Text] [Related]
7. Activated clotting time tests with heparinase in the management of pediatric patients on cardiopulmonary bypass.
Kriesmer P; Payne NR; Tessmer J; Uden DL
ASAIO J; 1993; 39(4):942-5. PubMed ID: 8123932
[TBL] [Abstract][Full Text] [Related]
8. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
9. Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart disease.
Guzzetta NA; Miller BE; Todd K; Szlam F; Moore RH; Brosius KK; Wilson EC; Cohen AM; Tosone SR
Anesth Analg; 2006 Nov; 103(5):1131-8. PubMed ID: 17056945
[TBL] [Abstract][Full Text] [Related]
10. The effect of heparin-coated pulmonary artery catheters on activated coagulation time in cardiac surgical patients.
Haering JM; Maslow AD; Parker RA; Lowenstein E; Comunale ME
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):260-3. PubMed ID: 10890477
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sufentanil and fentanyl for surgical repair of congenital cardiac defects.
Prakanrattana U; Suksompong S
J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S807-14. PubMed ID: 12452216
[TBL] [Abstract][Full Text] [Related]
12. Interchangeability of activated clotting time values across different point-of-care systems.
Thenappan T; Swamy R; Shah A; Nathan S; Nichols J; Bond L; Jolly N
Am J Cardiol; 2012 May; 109(9):1379-82. PubMed ID: 22341924
[TBL] [Abstract][Full Text] [Related]
13. Venous activated clotting time after intra-arterial heparin: effect of site of administration and timing of sampling.
Kerensky RA; Azar GJ; Bertolet B; Hill JA; Kutcher MA
Cathet Cardiovasc Diagn; 1996 Feb; 37(2):151-3. PubMed ID: 8808070
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac retrograde arterial catheterization in children under 2 years of age. Indications, techniques and complications].
Cherif A; Mourali S; Ezzar T; Aousji M; Farhati A; Boussaada R; Mechmeche R
Tunis Med; 2003; 81 Suppl 8():652-6. PubMed ID: 14608753
[TBL] [Abstract][Full Text] [Related]
15. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
Marmur JD; Lakhani M; El Rouby S; Cavusoglu E
J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
[TBL] [Abstract][Full Text] [Related]
17. The activated clotting time (ACT) can be used to monitor enoxaparin and dalteparin after intravenous administration.
Cavusoglu E; Lakhani M; Marmur JD
J Invasive Cardiol; 2005 Aug; 17(8):416-21. PubMed ID: 16079447
[TBL] [Abstract][Full Text] [Related]
18. Can analysis of the bispectral index prove helpful when monitoring titration of doses of midazolam and ketamine for sedation during paediatric cardiac catheterization.
Baysal A; Polat TB; Yalcin Y; Celebi A
Cardiol Young; 2008 Feb; 18(1):51-7. PubMed ID: 18093356
[TBL] [Abstract][Full Text] [Related]
19. Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization.
Mester R; Easley RB; Brady KM; Chilson K; Tobias JD
Am J Ther; 2008; 15(1):24-30. PubMed ID: 18223350
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant effect of iohexol vs. ioxaglate during cardiac catheterization.
Vacek JL; Hibiya K; Rosamond TL; Kramer PH; Crouse LJ; Robuck W; Beauchamp GD
J Invasive Cardiol; 1992 Apr; 4(3):139-44. PubMed ID: 10149895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
